Market Cap

NeoGenomics, Inc. Market Capitalization:

$1.52 Billion

USD as of Jan. 1, 2026

business NeoGenomics, Inc. Company Profile

NeoGenomics, Inc. Main Stock Listing

NASDAQ: NEO

Market Capitalization History of NeoGenomics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of NeoGenomics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.52 B -20.23%
Jan. 1, 2025 $1.91 B -4.14%
Jan. 1, 2024 $1.99 B 50.75%
Jan. 1, 2023 $1.32 B -53.22%
Jan. 1, 2022 $2.82 B -57.49%
Jan. 1, 2021 $6.64 B 64.51%
Jan. 1, 2020 $4.03 B 93.92%
Jan. 1, 2019 $2.08 B 115.28%
Jan. 1, 2018 $966.3 M -4.22%
Jan. 1, 2017 $1.01 B 18.18%
Jan. 1, 2016 $853.6 M 69.23%
Jan. 1, 2015 $504.4 M 0.75%
Jan. 1, 2014 $500.7 M 40.35%
Jan. 1, 2013 $356.7 M 62.86%
Jan. 1, 2012 $219.0 M 12.18%
Jan. 1, 2011 $195.3 M 6.85%
Jan. 1, 2010 $182.7 M 121.21%
Jan. 1, 2009 $82.6 M -35.92%
Jan. 1, 2008 $128.9 M -36.42%
Jan. 1, 2007 $202.8 M 671.43%
Jan. 1, 2006 $26.3 M -53.33%
Jan. 1, 2005 $56.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

NeoGenomics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

NeoGenomics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: NEO

Stock: BMV: NEO

Stock: FSX: NG9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.